McDermott Will & Emery acted as legal adviser to Neurovance, Inc. in its acquisition by a major Japanese pharmaceutical company Otsuka Pharmaceutical Co., Ltd. (OPC). Under…
Otsuka Pharmaceutical Co., Ltd.’s $250 million acquisition of Neurovance, Inc.
